Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Expert Opinion on Therapeutic Targets|November 12, 2014
Issues in interpreting the in vivo activity of Aurora-AElena Shagisultanova, Roland L Dunbrack, Erica A GolemisInternational Journal of Breast Cancer|July 19, 2018
Overcoming Therapeutic Resistance of Triple Positive Breast Cancer with CDK4/6 InhibitionTroy B Schedin, Virginia F Borges, Elena ShagisultanovaCurrent Breast Cancer Reports|August 30, 2021
Moving Towards Targeted Therapies for Triple-Negative Breast CancerJodi A Kagihara, Elena Shagisultanova, Anosheh Afghahi, et al.Gene|May 14, 2015
Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseasesElena Shagisultanova, Anna V Gaponova, Rashid Gabbasov, et al.JCO Precision Oncology|March 31, 2022
PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2-Positive Breast CancerAryana R Rasti, Amy Guimaraes-Young, Farrah Datko, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?Jagar Jasem, Christine M Fisher, Arya Amini, et al.Cancer Biology & Therapy|September 9, 2017
Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancerAvital Lev, Safoora Deihimi, Elena Shagisultanova, et al.Breast Cancer Research and Treatment|February 24, 2021
Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approvalEricson Stoen, Jodi Kagihara, Elena Shagisultanova, et al.Clinical Breast Cancer|July 3, 2025
Sequential Therapy With HER2 Tyrosine Kinase Inhibitors in Patients With HER2-Positive Metastatic Breast CancerElena Shagisultanova, Hannah Parris, Long Liu, et al.Molecular Cancer Therapeutics|November 3, 2021
Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2Elena Shagisultanova, Lyndsey S Crump, Michelle Borakove, et al.Pageof 2